In 2024, the trade exchange (includes international purchases and sales) of Medicaments Consisting of Mixed or Unmixed Products, Preparations for Therapeutic or Prophylactic Uses was US$7.48B.
In 2024, the states with the most international sales in Medicaments Consisting of Mixed or Unmixed Products, Preparations for Therapeutic or Prophylactic Uses were Ciudad de México (US$1.3B), Morelos (US$339M), Estado de México (US$282M), Jalisco (US$215M), and Baja California (US$53M).
The states with the most international purchases in 2024 were Ciudad de México (US$4.22B), Estado de México (US$693M), Jalisco (US$106M), Morelos (US$74.2M), and Chihuahua (US$48.9M).
In 2024, the main commercial destinations of Medicaments Consisting of Mixed or Unmixed Products, Preparations for Therapeutic or Prophylactic Uses were United States (US$999M), Colombia (US$243M), Canada (US$234M), Panama (US$127M), and Brazil (US$89.7M).
The main commercial origins of Medicaments Consisting of Mixed or Unmixed Products, Preparations for Therapeutic or Prophylactic Uses in 2024 were Germany (US$882M), United States (US$745M), Italy (US$396M), France (US$389M), and Ireland (US$335M).
In the global context, the main exporting countries of Medicaments Consisting of Mixed or Unmixed Products, Preparations for Therapeutic or Prophylactic Uses in 2022 were Germany (US$73.7B), Switzerland (US$43B), and United States (US$41.4B). In the same year, the main importing countries of Medicaments Consisting of Mixed or Unmixed Products, Preparations for Therapeutic or Prophylactic Uses were United States (US$88.2B), Germany (US$32.7B), and Switzerland (US$31.7B).